Our team made waves at this year’s Conference on Retroviruses and Opportunistic Infections, which took place in Denver, CO from March 3-6, 2024.

Several standout poster presentations showcased the incredible work of Pitt ID labs.

Patrick Mehta takes the lead on “Persons With Residual Viremia on ART Have Higher Frequencies of Myeloid-Derived Suppressor Cells.” He’s currently presenting in Denver alongside study mentor and coauthor, Dr. Bernard Macatangay, MD.

Joining the ID Pittstop crew at CROI is second-year ID fellow, Dr. Ralph Kamel, MD, presenting his poster, “Baseline KSHV T cell Responses are Associated with Pre-Treatment Clinical Presentation in KS,” where he serves as the leading author.

A few faculty members also displayed their posters at the vibrant Denver Convention Center this week. But the real question is, does the #bigbluebear, the towering 40ft sculpture, give its stamp of approval to these awe-inspiring research findings?